Idiopathic inflammatory myopathies
Figarella-Branger, D.; Lacroix, C.; Coquet, M.; Gherardi, R.; Pellissier, J.F.
Annales de Pathologie 21(3): 279-284
2001
ISSN/ISBN: 0242-6498 PMID: 11468572 Document Number: 532727
Document emailed within 1 workday
Related Documents
Gendek-Kubiak, H. 2005: Idiopathic inflammatory myopathies Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 18(107): 590-594Lundberg, I.E.; Forbess, C.J. 2008: Mortality in idiopathic inflammatory myopathies Clinical and Experimental Rheumatology 26(5 Suppl 51: S109-S114
Dugan, E.M.; Huber, A.M.; Miller, F.W.; Rider, L.G.; Bowyer, S.; Feldman, B.M.; Danko, K.; Garcia de la Torre, I.; Lang, B.; Lindsley, C.; Malleson, P.; Pachman, L.M.; Plotz, P.H.; Rennebohm, R.; Serratrice, J.; Sherry, D.; Sontheimer, R.; Song, Y.W.; Targoff, I.; Turner, M.; Vencovsky, J.; von Muhlen, C.A.; Werth, V.P.; Wortmann, R. 2009: Photoessay of the cutaneous manifestations of the idiopathic inflammatory myopathies Dermatology Online Journal 15(2): 1
Fraser, D.D.; Frank, J.A.; Dalakas, M.; Miller, F.W.; Hicks, J.E.; Plotz, P. 1991: Magnetic resonance imaging in the idiopathic inflammatory myopathies Journal of Rheumatology 18(11): 1693-1700
Pipitone, N.; Salvarani, C. 2007: Established and new treatments of the idiopathic inflammatory myopathies: dermatomyositis and polymyositis Clinical and Experimental Rheumatology 25(6): 896-906
Megens-de Letter, M.A.; Visser, L.H.; van Doorn, P.A.; Savelkoul, H.F. 1999: Cytokines in the muscle tissue of idiopathic inflammatory myopathies: implications for immunopathogenesis and therapy European Cytokine Network 10(4): 471-478
De Vita, S.; Fossaluzza, V. 1992: Treatment of idiopathic inflammatory myopathies with cyclophosphamide pulses: clinical experience and a review of the literature Acta Neurologica Belgica 92(4): 215-227
Scoppetta, C.; Casali, C.; D'Agostini, S.; Pauri, F.; Amabile, G. 1988: Inflammatory myopathies Rivista di Neurologia 58(1): 11-14
Larrauri, B.J.; Fernández Romero, D.S.; Juri, M.C.; Malbrán, A. 2016: Relapses in inflammatory myopathies Medicina 76(6): 379-382
Radhakrishnan, V.V.; Nair, M.D.; Kuruvilla, A.; Radhakrishnan, K. 1997: Inflammatory myopathies--a clinicopathologic study Indian Journal of Pathology and Microbiology 40(3): 315-320
Armbrustmacher, V.W.; Griffin, J.L. 1981: Pathology of inflammatory and metabolic myopathies Pathology Annual 16 Pt 1: 15-60
Chakour, R.; Leimgruber, A.; Bart, P.-A.; Spertini, F.ço. 2009: Therapeutic strategies in idiopatic inflammatory myopathies Revue Medicale Suisse 5(199): 812-818
Zámecník, J.; Vytásek, R.; Vencovský, J.; Vilím, V. 2011: Immunolocalization of protein-bound 3-nitrotyrosine in inflammatory myopathies Ceskoslovenska Patologie 47(2): 62-65
Bertorini, T.E. 1998: Inflammatory myopathies [polymyositis, dermatomyositis, inclusion body myositis Comprehensive Therapy 24(10): 494-502
Rowińska-Marcińska, K.; Szmidt-Sałkowska, E.; Kowalska, E.; Błaszczyk, M.; Drac, H.; Zakrzewska-Pniewska, B.; Karwańska, A.; Jabłońska, S.; Hausmanowa-Petrusewicz, I. 1994: Diagnostic yield of electrophysiological and immunological studies in inflammatory myopathies Neurologia i Neurochirurgia Polska 28(1 Suppl 1: 103-113
Kojima, S.; Takagi, A. 1993: Aberrant expression of major histocompatibility complex class Ii antigen in inflammatory myopathies Rinsho Shinkeigaku 33(6): 612-619
Gamstorp, I. 1971: Characteristic clinical findings in some neurogenic myopathies and in some myogenic myopathies causing muscular weakness, hypotonia and atrophy in infancy and early childhood Birth Defects Original Article Series 7(2): 72-81
Peiffer, J.; Bähr, M. 1987: Anomalies in perifascicular muscle fibers as an differential-diagnostic criterion. I. Perifascicular atrophy in inflammatory myopathies Clinical Neuropathology 6(3): 123-132
Reimund, J.M.; Duclos, B.; Baumann, R. 1996: Genetics and chronic idiopathic inflammatory diseases of the intestines Annales de Medecine Interne 147(3): 178-184
Garcia-Hernandez, F.J.; Gonzalez-Leon, R.; Castillo-Palma, M.J.; Sanchez-Roman, J. 2011: Rituximab is effective in the treatment of patients with idiopathic inflammatory myopathy Clinical and Experimental Rheumatology 29(2): 363-364